Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance \[CLcr\] decline and evidence of proximal tubulopathy).
Study Type
OBSERVATIONAL
Enrollment
56
A single whole blood sample was collected for genomic analysis.
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Miami, Florida, United States
Time to TDF discontinuation after diagnosis of Fanconi syndrome
Time frame: Up to 48 weeks
Time to confirmed resolution of Fanconi syndrome
Time frame: Up to 48 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Atlanta, Georgia, United States
University of Indiana
Indianapolis, Indiana, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Detroit, Michigan, United States
Unnamed facility
New York, New York, United States
Unnamed facility
Cleveland, Ohio, United States
Unnamed facility
Houston, Texas, United States
...and 3 more locations